One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors
Clinical trial NCT06781125 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06781125
- Sponsor
- Immorna Biotherapeutics, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-18
- Primary completion
- 2028-03-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.